Loading organizations...
§ Private Profile · Newton, MA, USA
Biopharmaceutical startup developing targeted cancer drugs.
Signet Therapeutics has raised $21.4M across 2 funding rounds.
Signet Therapeutics has raised $21.4M in total across 2 funding rounds.
Signet Therapeutics has raised $21.4M across 2 funding rounds. Most recently, it raised $11.4M Series A in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 14, 2026 | $11.4M Series A | — | Green Pine Capital Partners, Guoxing WEI, Shuhao WEN | Announced |
| Oct 29, 2021 | $10M Seed | Morningside | Sky9 Capital, Tiantu Capital | Announced |
Signet Therapeutics has raised $21.4M in total across 2 funding rounds.
Signet Therapeutics's investors include Green Pine Capital Partners, Guoxing Wei, Shuhao Wen, Morningside, Sky9 Capital, Tiantu Capital.